Alternating Electric Fields for the Trea...

GLP-1 receptor agonists are one of the most revolutionary new classes of drugs in decades. In this episode of Healthy Dialogue, host Derek C. Angus, MD, MPH, sat down with Jens Juul Holst, MD, DMSc, and Lotte Bjerre Knudsen, DMSc, 2 pioneering scientists behind the discovery and ... Show More

The United States has witnessed a staggering rise in obesity beginning in the early 1980s, leading to a wide array of important health consequences including heart disease, diabetes, and premature death. In this episode of Healthy Dialogue, Host Derek C. Angus, MD, MPH, talks wit ... Show More

This episode of Healthy Dialogue explores the history and future of science funding in the US in light of recent changes, and proposed changes, from the federal government. Host Derek Angus, MD, MPH, speaks with former editor in chief of Science and a former director of the Natio ... Show More

Interview with Kevin J. Contrera, MD, MPH, author of Neoadjuvant Therapy for Mucosal Head and Neck Squamous Cell Carcinoma: A Review From the American Head and Neck Society. Hosted by Paul C. Bryson, MD, MBA. Related Content: Neoadjuvant Therapy for Mucosal Head and Neck Squamous ... Show More

Interview with Monika Janda, PhD, author of 3D Total-Body Photography in Patients at High Risk for Melanoma: A Randomized Clinical Trial. Hosted by Adewole S. Adamson, MD. Related Content: 3D Total-Body Photography in Patients at High Risk for Melanoma 

Interview with Michael J. Brenner, MD, author of Liquid Biopsies for Head and Neck Cancers—Any Hope for Human Papillomavirus–Negative Disease? Hosted by Paul C. Bryson, MD, MBA. Related Content: Liquid Biopsies for Head and Neck Cancers—Any Hope for Human Papillomavirus–Negative ... Show More

Interview with Evan M. Graboyes, MD, MPH, author of Neighborhood-Level Disadvantage and Delayed Adjuvant Therapy in Head and Neck Cancer. Hosted by Paul C. Bryson, MD, MBA. Related Content: Neighborhood-Level Disadvantage and Delayed Adjuvant Therapy in Head and Neck Cancer 

In this week's episode, Blood editor Dr. Laura Michaelis interviews author Dr. Taylor Brooks on his latest paper published in volume 146 issue 18 of Blood Journal. The conversation discusses outcomes of bispecific antibodies (epcoritamab or glofitamab) in treating aggressive B-ce ... Show More

Interview with Jennifer M. Johnson, MD, PhD and Adam J. Luginbuhl, MD authors of A Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab. Hosted by Paul C. Bryson, MD MBA. Related Content: Pathologic Treatment Effect and Survival in HPV-Ne ... Show More

Interview with Harry A. Quigley, MD, author of Shedding LiGHT on Selective Laser Trabeculoplasty, and guest Michael A. Kass, MD, Washington University School of Medicine in St Louis. Hosted by Neil M. Bressler, MD. Related Content: Shedding LiGHT on Selective Laser Trabeculoplast ... Show More

Interview with Katherine A. Hutcheson, PhD, author of Manual Therapy for Fibrosis-Related Late Effect Dysphagia in Head and Neck Cancer Survivors: The MANTLE Nonrandomized Clinical Trial. Hosted by Paul C. Bryson, MD, MBA. Related Content: Manual Therapy for Fibrosis-Related Late ... Show More

Interview with Jay F. Piccirillo, MD, author of Efficacy of Gabapentin For Post–COVID-19 Olfactory Dysfunction: The GRACE Randomized Clinical Trial. Hosted by Paul C. Bryson, MD, MBA. Related Content: Efficacy of Gabapentin For Post–COVID-19 Olfactory Dysfunction